Bristol-Myers Squibb

YTD

ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.

CEO

Christopher S. Boerner

CEOChristopher S. Boerner

Employees

32,500

Employees32,500

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

1933

Founded1933

Employees

32,500

Employees32,500

BMY Key Statistics

Market cap

127.61B

Market cap127.61B

Price-Earnings ratio

13.84

Price-Earnings ratio13.84

Dividend yield

4.02%

Dividend yield4.02%

Average volume

10.79M

Average volume10.79M

High today

$64.04

High today$64.04

Low today

$62.10

Low today$62.10

Open price

$62.87

Open price$62.87

Volume

12.67M

Volume12.67M

52 Week high

$68.64

52 Week high$68.64

52 Week low

$45.20

52 Week low$45.20

Stock Snapshot

As of today, Bristol-Myers Squibb(BMY) shares are valued at $62.55. The company's market cap stands at 127.61B, with a P/E ratio of 13.84 and a dividend yield of 4.02%.

As of 2026-11-01, Bristol-Myers Squibb(BMY) stock has fluctuated between $62.10 and $64.04. The current price stands at $62.55, placing the stock +0.7% above today's low and -2.3% off the high.

The Bristol-Myers Squibb(BMY)'s current trading volume is 12.67M, compared to an average daily volume of 10.79M.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.20 at its lowest and $68.64 at its peak.

BMY News

Simply Wall St 5h

Why Everyone Is Watching Bristol-Myers Squibb Today

Bristol-Myers Squibb (BMY) just lifted its 2026 guidance after reporting 7% revenue growth in the latest quarter, tying that outlook upgrade to momentum in key...

Simply Wall St 2d

Is Bristol-Myers Squibb Stock Cheap, Or Are Risks Priced In?

has had a strong run over the past year, and recent trial updates plus fresh AI partnerships have kept the story moving. With the stock now reflecting a mix of...

The Motley Fool 2d

Bristol Myers’ Growth Drugs Hit $7.7 Billion: Rapid Earnings Reaction

Bristol Myers Squibb's (BMY +0.06%) Growth Portfolio of newer drugs grew 12% to $7.7 billion in the third quarter, supplying nearly all of the company's 7% reve...

Analyst ratings

58%

of 31 ratings

Buy

35.5%

Hold

58.1%

Sell

6.5%

More BMY News

Zacks 6d

Should You Buy, Hold, or Sell BMY Stock Ahead of Q3 Earnings?

Biotech giant Bristol-Myers Squibb Company (BMY Quick QuoteBMY - Free Report) is scheduled to report third-quarter 2026 results on Oct. 29, before market...

Zacks 6d

Bristol Myers Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

The upcoming report from Bristol Myers Squibb (BMY Quick QuoteBMY - Free Report) is expected to reveal quarterly earnings of $1.28 per share, indicating...

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.